These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 28212710)

  • 1. CTRP1 in Liver Disease.
    Shabani P; Emamgholipour S; Doosti M
    Adv Clin Chem; 2017; 79():1-23. PubMed ID: 28212710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating level of CTRP1 in patients with nonalcoholic fatty liver disease (NAFLD): is it through insulin resistance?
    Shabani P; Naeimi Khaledi H; Beigy M; Emamgholipour S; Parvaz E; Poustchi H; Doosti M
    PLoS One; 2015; 10(3):e0118650. PubMed ID: 25767880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C1q/TNF-related Protein 1, a Multifunctional Adipokine: An Overview of Current Data.
    Janowska JD
    Am J Med Sci; 2020 Sep; 360(3):222-228. PubMed ID: 32591091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of adipokines and insulin resistance in the pathogenesis of nonalcoholic fatty liver disease].
    Orlik B; Handzlik G; Olszanecka-Glinianowicz M
    Postepy Hig Med Dosw (Online); 2010 May; 64():212-9. PubMed ID: 20498498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel adipokine CTRP1 stimulates aldosterone production.
    Jeon JH; Kim KY; Kim JH; Baek A; Cho H; Lee YH; Kim JW; Kim D; Han SH; Lim JS; Kim KI; Yoon DY; Kim SH; Oh GT; Kim E; Yang Y
    FASEB J; 2008 May; 22(5):1502-11. PubMed ID: 18171693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular, biochemical and functional characterizations of C1q/TNF family members: adipose-tissue-selective expression patterns, regulation by PPAR-gamma agonist, cysteine-mediated oligomerizations, combinatorial associations and metabolic functions.
    Wong GW; Krawczyk SA; Kitidis-Mitrokostas C; Revett T; Gimeno R; Lodish HF
    Biochem J; 2008 Dec; 416(2):161-77. PubMed ID: 18783346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CTRP1 protects against diet-induced hyperglycemia by enhancing glycolysis and fatty acid oxidation.
    Han S; Park JS; Lee S; Jeong AL; Oh KS; Ka HI; Choi HJ; Son WC; Lee WY; Oh SJ; Lim JS; Lee MS; Yang Y
    J Nutr Biochem; 2016 Jan; 27():43-52. PubMed ID: 26456564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adiponectin: A multitasking player in the field of liver diseases.
    Silva TE; Colombo G; Schiavon LL
    Diabetes Metab; 2014 Apr; 40(2):95-107. PubMed ID: 24486145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonalcoholic steatohepatitis versus steatosis: adipose tissue insulin resistance and dysfunctional response to fat ingestion predict liver injury and altered glucose and lipoprotein metabolism.
    Musso G; Cassader M; De Michieli F; Rosina F; Orlandi F; Gambino R
    Hepatology; 2012 Sep; 56(3):933-42. PubMed ID: 22684858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adiponectin: no longer the lone soul in the fight against insulin resistance?
    Davis KE; Scherer PE
    Biochem J; 2008 Dec; 416(2):e7-9. PubMed ID: 18990088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CTRP1: A novel player in cardiovascular and metabolic diseases.
    Wang Y; Li H; Yu XH; Tang CK
    Cytokine; 2023 Apr; 164():156162. PubMed ID: 36812667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of adiponectin in the pathogenesis and treatment of non-alcoholic fatty liver disease.
    Polyzos SA; Kountouras J; Zavos C; Tsiaousi E
    Diabetes Obes Metab; 2010 May; 12(5):365-83. PubMed ID: 20415685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
    Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
    Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adipokines in liver diseases.
    Marra F; Bertolani C
    Hepatology; 2009 Sep; 50(3):957-69. PubMed ID: 19585655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C1q/TNF-related protein-1 functions to protect against acute ischemic injury in the heart.
    Yuasa D; Ohashi K; Shibata R; Mizutani N; Kataoka Y; Kambara T; Uemura Y; Matsuo K; Kanemura N; Hayakawa S; Hiramatsu-Ito M; Ito M; Ogawa H; Murate T; Murohara T; Ouchi N
    FASEB J; 2016 Mar; 30(3):1065-75. PubMed ID: 26578687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel adipokine C1q/TNF-related protein 1 (CTRP1) regulates chondrocyte proliferation and maturation through the ERK1/2 signaling pathway.
    Akiyama H; Otani M; Sato S; Toyosawa S; Furukawa S; Wakisaka S; Maeda T
    Mol Cell Endocrinol; 2013 Apr; 369(1-2):63-71. PubMed ID: 23348620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated CTRP1 Plasma Concentration Is Associated with Sepsis and Pre-Existing Type 2 Diabetes Mellitus in Critically Ill Patients.
    Yagmur E; Buergerhausen D; Koek GH; Weiskirchen R; Trautwein C; Koch A; Tacke F
    J Clin Med; 2019 May; 8(5):. PubMed ID: 31083558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance.
    Asrih M; Jornayvaz FR
    J Endocrinol; 2013 Sep; 218(3):R25-36. PubMed ID: 23833274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
    Højlund K
    Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The novel adipokine CTRP1 is significantly associated with the incidence of major adverse cardiovascular events.
    Muendlein A; Leiherer A; Saely C; Ebner J; Geiger K; Brandtner EM; Vonbank A; Fraunberger P; Drexel H
    Atherosclerosis; 2019 Jul; 286():1-6. PubMed ID: 31051410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.